| Literature DB >> 32314971 |
Yuyu Jiang1, Fenglan Liu1, Jianlan Guo1, Pingping Sun1, Zhongyi Chen1, Jinping Li2, Liming Cai3, Hongqing Zhao4, Ping Gao5, Zhaosheng Ding6, Xiaoliang Wu7.
Abstract
BACKGROUND: The application of telemedicine in home pulmonary rehabilitation interventions for the management of patients with chronic obstructive pulmonary disease (COPD) has achieved promising results.Entities:
Keywords: WeChat; chronic obstructive pulmonary disease; randomized controlled trial; self-efficacy; telemedicine; the eHealth enhanced chronic care model
Mesh:
Year: 2020 PMID: 32314971 PMCID: PMC7201319 DOI: 10.2196/17089
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Mapping table of the Pulmonary Internet Explorer Rehabilitation function module.
| Components of the eCCMa | Characteristic | PeRb function module |
| eCommunity |
Participation, active, self-management |
PeR moments |
| Communication and the addition of the complete feedback loop |
Communication, complete feedback Control over the timing |
Appointment for medical treatment Medical guidance |
| Clinical information systems enhancements |
Register Database Support access |
Register log-in Rehabilitation effect database Self-report database |
| Self-management support enhancements |
Education (information) Behavior support (an aid to behavioral change) |
Respiratory training Diet guidance Medication knowledge Exercise training Integral mall |
| Add self-efficacy resource component |
Mastery experience Alternative experience Verbal persuasion Physiological and emotional state |
Respiratory training Diet guidance Medication knowledge Exercise training Integral mall |
aeCCM: electronic health–enhanced chronic care model.
bPeR: Pulmonary Internet Explorer Rehabilitation.
Figure 1Functional modules of Pulmonary Internet Explorer Rehabilitation on the WeChat terminal.
Figure 2Patient log-in process.
Figure 3Consolidated Standards of Reporting Trials flowchart.
Basic demographic characteristics and measurements of the two groups.
| Characteristics | PeRa group, (n=53) | FtFb group, (n=53) | Total, (n=106) | ||||
|
| — | — | — | 0.06 (1) | — | .50 | |
|
| Male | 44 (83) | 43 (81) | 87 (82) | — | — | — |
|
| Female | 9 (17) | 10 (19) | 19 (18) | — | — | — |
| Age, mean (SD) | 70.92 (6.38) | 71.83 (7.60) | — | — | –0.67 (104) | .51 | |
| BMIc, mean (SD) | 22.21 (3.52) | 21.27 (2.36) | — | — | 1.62 (90.84) | .11 | |
|
| — | — | — | 0.05 (1) | — | >.99 | |
|
| <10 years | 16 (30) | 15 (28) | 31 (29) | — | — | — |
|
| ≥10 years | 37 (70) | 38 (72) | 75 (71) | — | — | — |
|
| — | — | — | 3.58 (3) | — | .31 | |
|
| Primary school | 12 (23) | 13 (25) | 25 (24) | — | — | — |
|
| Middle school | 15 (28) | 22 (42) | 37 (35) | — | — | — |
|
| High school | 17 (32) | 14 (26) | 31 (29) | — | — | — |
|
| Higher school | 9 (17) | 4 (8) | 13 (12) | — | — | — |
|
| — | — | — | 0.00 (2) | — | >.99 | |
|
| No | 12 (23) | 12 (23) | 24 (23) | — | — | — |
|
| Exsmoker | 35 (66) | 35 (66) | 70 (66) | — | — | — |
|
| Current smoker | 6 (11) | 6 (11) | 12 (11) | — | — | — |
| — | — | — | 6.69 (3) | — | .08 | ||
|
| GOLD II | 27 (50.9) | 20 (38) | 47 (44) | — | — | — |
|
| GOLD III | 15 (28.3) | 27 (51) | 42 (40) | — | — | — |
|
| GOLD IV | 11 (21) | 6 (11) | 17 (16) | — | — | — |
|
| — | — | — | — | — | — | |
|
| CATe | 21.79 (6.85) | 22.55 (6.48) | — | — | –0.58 (104) | .56 |
|
| Ex-SRESf | 72.25 (38.38) | 71.48 (40.76) | — | — | 0.10 (104) | .92 |
|
| mMRCg | 2.79 (0.66) | 2.75 (0.71) | — | — | 0.28 (104) | .78 |
|
| SGRQ-Sh | 53.02 (19.90) | 51.12 (18.63) | — | — | 0.51 (104) | .61 |
|
| SGRQ-Ai | 56.44 (23.96) | 56.87 (22.47) | — | — | –0.09 (104) | .93 |
|
| SGRQ-Ij | 45.82 (24.27) | 44.92 (18.69) | — | — | 0.22 (104) | .83 |
|
| SGRQ-Tk | 50.24 (20.95) | 49.57 (17.52) | — | — | 0.18 (104) | .86 |
aPeR: Pulmonary Internet Explorer Rehabilitation.
bFtF: face to face.
cBMI: body mass index.
dGOLD: Global Initiative for Chronic Obstructive Lung Disease; GOLD II: FEV1/FVC<70%, 50%≤FEV1<80%; GOLD III: FEV1/FVC<70%, 30%≤FEV1<50%; GOLD IV: FEV1/FVC<70%, FEV1<30%.
eCAT: chronic obstructive pulmonary disease assessment test.
fEx-SRES: exercise self-regulatory efficacy scale.
gmMRC: modified Medical Research Council scale.
hSGRQ-S: St George’s Respiratory Questionnaire–System.
iSGRQ-A: St George’s Respiratory Questionnaire–Activity.
jSGRQ-I: St George’s Respiratory Questionnaire–Influence.
kSGRQ-T: St George’s Respiratory Questionnaire–Total.
Figure 4Chronic obstructive pulmonary disease assessment test score and its change over time.
Variation tendency of chronic obstructive pulmonary disease assessment test, exercise self-regulatory efficacy scale, and modified Medical Research Council scale scores in the two groups.
| Item and group | CATa | Ex-SRESb | mMRCc | |||
|
|
|
|
| |||
| Time | 7.78 | .001 | 21.91 | <.001 | 29.64 | <.001 |
| Group | 0.39 | .53 | 0.23 | .63 | 0.00 | >.99 |
| Time×group | 0.02 | .98 | 2.02 | .14 | 0.8 | .43 |
aCAT: chronic obstructive pulmonary disease assessment test.
bEx-SRES: exercise self-regulatory efficacy scale.
cmMRC: modified Medical Research Council scale.
Comparison of chronic obstructive pulmonary disease assessment test, exercise self-regulatory efficacy scale, modified Medical Research Council scale, and St George’s Respiratory Questionnaire scores between the two groups before and after intervention.
| Outcomes | Baseline | After intervention (3 months) | After intervention (6 months) | ||
|
|
|
|
|
| |
|
| PeRd group, mean (SD) | 21.79 (6.85) | 20.98 (6.99) | 20.85 (7.11) | 3.70 (.02) |
|
| FtFe group, mean (SD) | 22.55 (6.48) | 21.75 (6.25) | 21.70 (6.69) | 4.17 (.02) |
|
| 10.14 (.002) | — | — | — | |
|
| — | 0.15 (.70) | — | — | |
|
| — | — | 12.80 (.001) | — | |
|
|
|
|
|
| |
|
| PeR group, mean (SD) | 72.25 (38.38) | 85.36 (33.18) | 80.53 (37.72) | 17.22 (<.001) |
|
| FtF group, mean (SD) | 71.48 (40.76) | 78.49 (33.94) | 78.25 (35.40) | 6.47 (.008) |
|
| 54.10 (<.001) | — | — | — | |
|
| — | 3.99 (.05) | — | — | |
|
| — | — | 14.12 (<.001) | — | |
|
|
|
|
|
| |
|
| PeR group, mean (SD) | 2.79 (0.66) | 2.51 (0.72) | 2.40 (0.79) | 14.73 (<.001) |
|
| FtF group, mean (SD) | 2.75 (0.70) | 2.58 (0.69) | 2.36 (0.71) | 15.77 (<.001) |
|
| 21.54 (<.001) | — | — | — | |
|
| — | 14.06 (<.001) | — | — | |
|
| — | — | 43.97 (<.001) | — | |
|
|
|
|
|
| |
|
| PeR group, mean (SD) | 53.02 (19.90) | — | 43.59 (23.63) | 3.59 (.001) |
|
| FtF group, mean (SD) | 51.12 (18.63) | — | 45.33 (22.25) | 2.89 (.006) |
|
| — | — | –1.10 (.27) | — | |
|
|
|
|
|
| |
|
| PeR group, mean (SD) | 56.44 (23.96) | — | 48.74 (24.28) | 3.01 (.004) |
|
| FtF group, mean (SD) | 56.87 (22.47) | — | 53.46 (23.06) | 2.89 (.006) |
|
| — | — | –1.53 (.13) | — | |
|
|
|
|
|
| |
|
| PeR group, mean (SD) | 45.83 (24.27) | — | 33.27 (22.86) | 3.89 (<.001) |
|
| FtF group, mean (SD) | 44.92 (18.69) | — | 38.63 (21.88) | 3.65 (.001) |
|
| — | — | –1.71 (.09) | — | |
|
|
|
|
|
| |
|
| PeR group, mean (SD) | 50.24 (20.95) | — | 39.66 (20.92) | 4.06 (<.001) |
|
| FtF group, mean (SD) | 49.57 (17.52) | — | 44.24 (19.90) | 3.84 (<.001) |
|
| — | — | –1.78 (.08) | — | |
aF1,3: repeated measures analysis of variance.
bt3: 6 months compared with baseline.
cCAT: chronic obstructive pulmonary disease assessment test.
dPeR: Pulmonary Internet Explorer Rehabilitation.
eFtF: face-to-face.
fF1: 3 months compared with baseline.
gF2: 6 months compared with 3 months.
hF3: 6 months compared with baseline.
iEx-SRES: exercise self-regulatory efficacy scale.
jmMRC: modified Medical Research Council scale.
kSGRQ-S: St George’s Respiratory Questionnaire–System.
lt: comparison among groups.
mSGRQ-A: St George’s Respiratory Questionnaire–Activity.
nSGRQ-I: St George’s Respiratory Questionnaire–Influence.
oSGRQ-T: St George’s Respiratory Questionnaire–Total.
Figure 5Exercise self-regulatory efficacy scale score and its change over time.
Figure 6Modified Medical Research Council scale score and its change over time.
Analysis of the influence of intervention methods, intervention time, and self-efficacy on patients’ quality of life using the generalized estimating equation.
| Parameter |
| SE | Wald | Exp | |
| Constant | –1.62 | 0.33 | 24.33 | <.001 | 0.20 |
| Intervention methods | –0.25 | 0.35 | 0.49 | .48 | 0.78 |
| Ex-SRESa | 0.81 | 0.38 | 4.63 | .03 | 2.24 |
| Intervention time | –0.07 | 0.35 | 0.04 | .84 | 0.93 |
| Intervention methods×Ex-SRES | 0.75 | 0.49 | 2.34 | .13 | 2.12 |
| Intervention methods×intervention time | 0.10 | 0.51 | 0.03 | .85 | 1.10 |
| Ex-SRES×intervention time | 0.97 | 0.56 | 2.96 | .09 | 2.64 |
| Intervention methods×Ex-SRES×intervention time | –1.86 | 1.05 | 3.16 | .08 | 0.16 |
aEx-SRES: exercise self-regulatory efficacy scale.